Viking Therapeutics, Inc. (VKTX)

30.77 -0.33 (-1.06%) USD  |  NASDAQ  |  Feb 20, 13:46
More

Viking Therapeutics Price Target Std Dev

Price Target Std Dev Chart

View Price Target Std Dev for VKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Std Dev Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Std Dev Range, Past 5 Years

View Price Target Std Dev Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Std Dev Benchmarks

View Price Target Std Dev Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Amgen, Inc. Upgrade
Biogen, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade